A STUDY ON VENTILATOR ASSOCIATED PNEUMONIA IN PEDIATRIC AGE GROUP IN A TERTIARY CARE HOSPITAL, VADODARA

Abstract

Introduction: Approximately 10-28% of critical care patients develop Ventilator Associated Pneumonia (VAP). It increases length of stay in ICU up to 28% and each incidence ofVentilator-associated pneumonia(VAP) is estimated to generate an increased cost of £6000-£22000. Mortality rate is 24%-71%. Objectives: To determine the incidence rate, bacteriological profile and antibiotic sensitivity pattern of ventilator-associated pneumonia in pediatric intensive care unit (PICU) & Neonatal intensive care unit(NICU) Methods: In this study total 125 patients of pediatric age group admitted in ICU & put on ventilator at SSGH from November 2010 to November 2011 were enrolled. After the clinical confirmation according to CDC criteria, the endotracheal secretion were collected and processed as per standard microbiological methods and antibiotic sensitivity pattrn of each were recorded. Results: Of total 125 samples 58 samples were positive. Most common Organism isolated are Klebseilla spp.(35%), Acinetobactor spp.(26%), Psedomonas spp.(15%),other enterobactriacae(13%), Gram positive cocci(8%) and candida spp(3%). Among the isolates for Gram Negative Bacilli – Imipenem and Vancomycin for Gram Positive Cocci is recommended. Conclusion: Among the isolates for Gram Negative Bacilli – Imipenem and Vancomycin for Gram Positive Cocci is recommended

Keywords

• ventilator associated pneumonia
• CDC guidelines of VAP
• Endotracheal aspirate culture